Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Operating Margin (2016 - 2025)

Macrogenics (MGNX) has disclosed Operating Margin for 14 consecutive years, with 29.34% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 10275.0% to 29.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48.72% through Dec 2025, up 1907.0% year-over-year, with the annual reading at 48.72% for FY2025, 2501.0% up from the prior year.
  • Operating Margin for Q4 2025 was 29.34% at Macrogenics, down from 25.59% in the prior quarter.
  • The five-year high for Operating Margin was 48.95% in Q3 2024, with the low at 1763.06% in Q2 2024.
  • Average Operating Margin over 5 years is 310.95%, with a median of 234.56% recorded in 2021.
  • The sharpest move saw Operating Margin tumbled -142078bps in 2024, then surged 159779bps in 2025.
  • Over 5 years, Operating Margin stood at 411.65% in 2021, then skyrocketed by 104bps to 16.39% in 2022, then plummeted by -2908bps to 460.39% in 2023, then surged by 71bps to 132.09% in 2024, then soared by 78bps to 29.34% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 29.34%, 25.59%, and 165.27% for Q4 2025, Q3 2025, and Q2 2025 respectively.